Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician
1.1 Management approaches
Table of contents
- Acknowledgments
- Abbreviations
- Preface
- Introduction
1. Levels of evidence
2. Management of people with comorbidity of mental disorders and substance use- 3. The common drug groups
- 4. Tobacco
- 5. Depression and substance use
- 6. Anxiety disorders and substance use
- 7. Psychosis (schizophrenia and bipolar disorder) and substance use
- 8. Personality disorders and substance use
- 9. Eating disorders and substance use
- 10. Somatoform disorders and substance use
- 11. Gambling and substance use
- 12. Brain injury, mental disorders and substance use
- 13. Bibliography
- 14. Appendices
In these guidelines, the quality of scientific evidence supporting statements concerning clinical practice is indicated by the following indications of 'level of evidence':
1.1.1 Level of Evidence
**** Strong - Systematic review of multiple randomised controlled trials (RCT) OR multiple RCTs with consistent findings.
*** Good - At least one RCT or multiple comparative (non-randomised) studies with consistent findings.
** Moderate - Any form of comparative (non-randomised) study.
* Some - Case series (single treatment group).
No Rating - No experimental studies - any statements are based on single case reports or clinical opinion/ expertise.
The system of rating the level of evidence draws on the system used by the National Health and Medical Research Council (NH&MRC) of Australia (A guide to the development, implementation and evaluation of clinical practice guidelines. Canberra: NH&MRC, 1999. www.nhmrc.gov.au/publications/synopses/cp65syn.htm), and the Australian National Council on Drugs (ANCD) (Monograph 4).
